A day in the life… page 4

Article

A day in the life

Previous page

Time to reflect

We usually finish morning clinic between 2 and 2.30 pm, and finally at this point we can relax. During this time we speak of our projects, work in progress, research programmes and participation in upcoming congresses.

One of the best things about our team is the friendliness and comradeship amongst us. It would be very difficult for somebody who has a different work ethic to mix with us. I therefore select our team members very carefully to make sure that their personality, as well as their skills, matches our team. I can honestly say that we are a nice team, and work is certainly more pleasant if the setting is relaxed.

No rest for the wicked

I begin my private practice in the afternoon, usually at 3.00 pm. My office is not in the hospital, but in an historic building very close to the city's cathedral. By the time I arrive, my secretary and my first patients are usually already there.

My practice is retina-oriented, but it is a general ophthalmology practice. My patient base is much smaller than that in the morning clinic, my working rhythm is far more relaxed and thankfully my patients are usually on time for their appointments.

My working day with patients finally comes to an end at around 7.00 pm but I usually stay in my office at least for another hour to read my e-mails, connect to the web, answer letters, and to organise the administrative aspects of my work.

After these tasks, my working day comes to an end and I can recharge my batteries ready for another day at the clinic to begin!

Previous page

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.